ITRI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Itron is not a clear buy right now for a beginner long-term investor with $50,000-$100,000, especially for someone who does not want to wait for a better entry. The stock has some constructive long-term positives, but the current setup is mixed: price is near support, momentum is only neutral-to-slightly positive, moving averages are still bearish, and analyst targets have been cut across the board after a weaker near-term guide. My direct view is to hold off on buying now and wait for a stronger technical confirmation or a more attractive pullback.
Pre-market price is 81.86, essentially flat at +0.01%. The MACD histogram is positive and expanding, which supports short-term momentum improvement. RSI_6 at 51.8 is neutral, so there is no strong overbought or oversold signal. However, the moving averages remain bearish with SMA_200 > SMA_20 > SMA_5, which means the broader trend is still not fully bullish. Price is sitting near pivot support at 80.742, with resistance at 82.919 and 84.264. In short, the stock is trying to stabilize, but the trend is not strong enough to call this a high-conviction buy today.
["TD Cowen, Roth Capital, Baird, Oppenheimer, JPMorgan, and Needham all retain bullish or constructive long-term views despite lower near-term targets.", "Needham highlighted Itron's structurally dominant position in North American smart metering and a multi-year AMI 2.0 replacement cycle.", "JPMorgan cited a catalyst-rich environment tied to data center contract announcements and order volumes.", "Recent news shows Itron completed a smart water management project in Thane, supporting execution in digital infrastructure.", "MACD is improving and price is holding near support, which can help the stock base for a recovery."]
["Raymond James Underperform rating and sector normalization concerns", "Lowered price targets after Q1 results and weak Q2 guidance", "Bearish moving average structure"]
Latest quarter financial details were not provided because the financial snapshot returned an error. Based on analyst commentary for 1Q26, Itron beat expectations due to a pull-forward effect, but 2Q26 guidance came in below expectations. That implies near-term growth is softer, even though longer-term business quality and margin improvement themes remain intact. The latest referenced quarter season is Q1 2026.
Wall Street remains mixed but still mostly constructive. Several firms kept Buy/Outperform/Overweight-style ratings, but nearly all lowered price targets after the quarter, which signals reduced near-term optimism. TD Cowen cut to $130 from $145, Roth to $136 from $150, Baird to $118 from $128, JPMorgan to $113 from $133, and Oppenheimer raised its target slightly to $135 from $133. Raymond James stands out as bearish with an Underperform rating and a view that the stock may be worth about 30% below current prices. Overall, pros still like the long-term story, but near-term expectations have clearly cooled.
